Melbourne Connect
Level 7 700 Swanston Street
Carlton, VIC 3053
Australia
61 3 9545 5940
https://4dmedical.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 131
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. Andreas Fouras M.A.I.C.D., Ph.D. | Founder, MD, CEO & Director | 537.75k | N/D | N/D |
Mr. Simon Glover | Chief Financial Officer | 227.54k | N/D | N/D |
Mr. John Andrew Livingston BAppSci, GradCertBus, GradDipHSc | Executive Director | 116.64k | N/D | N/D |
Ms. Naomi Lawrie | Company Secretary & General Counsel | N/D | N/D | N/D |
Ms. Rachael Tenkaten | Chief of Staff | N/D | N/D | N/D |
Dr. Aidan Jamison B.E., Ph.D. | Senior Vice President of Engineering | N/D | N/D | N/D |
Dr. Michael Curtis Ph.D. | Chief Software Architect | N/D | N/D | N/D |
Dr. Jon Dusting Ph.D. | Chief Research Officer | N/D | N/D | N/D |
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
La calificación ISS Governance QuickScore de 4DMedical Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.